M&T Bank
KDNY

M&T Bank’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

M&T Bank’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-113,312
Closed -$11M – 1861
2015
Q3 		$11M Sell
113,312
-117
-0.1% -$13.9K 0.07% 213
2015
Q2 		$17.2M Buy
+113,429
New +$18.7M 0.1% 174

Other funds holding KDNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

M&T Bank's KDNY Position: Q4 2015 in Review

M&T Bank sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q4 2015, closing a stake of 113,312 shares — an estimated $11M sold.

M&T Bank first reported a position in KDNY in Q2 2015 and held it in 2 quarters. The position peaked at $17.2M in Q2 2015. 87 funds tracked by Wall St. Rank hold KDNY as of Q4 2015.

  • M&T Bank reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • M&T Bank sold 113,312 Chinook Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $11M.
  • M&T Bank first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 2 quarters.
  • M&T Bank's Chinook Therapeutics, Inc. Common Stock position peaked at $17.2M in Q2 2015.
  • 87 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q4 2015.

Based on M&T Bank's 13F filing for Q4 2015, filed 12 Feb 2016.